Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4894416 | 5975848 | I | 4894416-7 | 20000301 | 20051130 | 20051230 | EXP | 427074 | HOFFMANN-LA ROCHE INC. | 43 | YR | M | N | 20051212 | FRANCE |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4894416 | 1006875519 | PS | INTERFERON ALFA (INTERFERON ALFA) | 2 | SUBCUTANEOUS | 3 MILLIONIU 3 PER 1 WEEK SUBCUTANEOUS | Y | D | |||
| 4894416 | 1006897837 | SS | RIBAVIRIN | 1 | 800 MG DAILY | Y | D |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 4894416 | 1006875519 | HEPATITIS C |
| 4894416 | 1006897837 | HEPATITIS C |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 4894416 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 4894416 | ARTHRALGIA |
| 4894416 | COLITIS ULCERATIVE |
| 4894416 | CROHN'S DISEASE |
| 4894416 | DRUG DEPENDENCE |
| 4894416 | GENERAL PHYSICAL HEALTH DETERIORATION |
| 4894416 | IRON DEFICIENCY ANAEMIA |
| 4894416 | JOINT EFFUSION |
| 4894416 | PYODERMA GANGRENOSUM |
| 4894416 | WEIGHT DECREASED |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 4894416 | FGN |
| 4894416 | HP |
| 4894416 | LIT |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 4894416 | 1006875519 | 20000215 | 20000815 | ||
| 4894416 | 1006897837 | 20000215 | 20000815 |